Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.84M Buy
+102,926
New +$2.27M ﹤0.01% 3528
2025
Q3
Sell
-517,127
Closed -$8.13M 6405
2025
Q2
$8.13M Buy
+517,127
New +$7.84M ﹤0.01% 2485
2024
Q4
Sell
-230,147
Closed -$6.44M 6400
2024
Q3
$6.44M Buy
+230,147
New +$6.5M ﹤0.01% 2618
2024
Q2
Sell
-13,690
Closed -$299K 6447
2024
Q1
$299K Sell
13,690
-273,380
-95% -$5.86M ﹤0.01% 5143
2023
Q4
$6.68M Buy
287,070
+88,719
+45% +$1.79M ﹤0.01% 2536
2023
Q3
$3.91M Buy
+198,351
New +$3.91M ﹤0.01% 2939
2023
Q2
Sell
-110,600
Closed -$2.17M 6611
2023
Q1
$2.17M Sell
110,600
-1,053,954
-91% -$20.2M ﹤0.01% 3364
2022
Q4
$20M Buy
+1,164,554
New +$20.7M 0.01% 1443

Other funds holding RXO

Israel Englander's RXO Position: Q2 2026 in Review

Israel Englander opened a new position in RXO (RXO) in Q2 2026: 102,926 shares worth $2.84M. The stake represents ﹤0.01% of the portfolio and ranks #3528 among its holdings. This is a return to the name: Israel Englander previously reported a position in RXO as recently as Q2 2025.

Israel Englander first reported a position in RXO in Q4 2022 and has held it in 8 quarters since. The position peaked at $20M in Q4 2022. 302 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • Israel Englander held 102,926 shares of RXO worth $2.84M as of Q2 2026.
  • RXO was a new Israel Englander position in Q2 2026.
  • RXO made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3528 holding.
  • Israel Englander first reported a position in RXO in Q4 2022 and has held it in 8 quarters since.
  • Israel Englander's RXO position peaked at $20M in Q4 2022.
  • 302 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.